The latest price target for PolyPid (NASDAQ:PYPD) was reported by Roth Capital on November 13, 2025. The analyst firm set a price target for $9.00 expecting PYPD to rise to within 12 months (a possible 123.05% upside). 10 analyst firms have reported ratings in the last year.

The latest analyst rating for PolyPid (NASDAQ:PYPD) was provided by Roth Capital, and PolyPid maintained their buy rating.

There is no last upgrade for PolyPid

There is no last downgrade for PolyPid.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PolyPid, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PolyPid was filed on November 13, 2025 so you should expect the next rating to be made available sometime around November 13, 2026.

While ratings are subjective and will change, the latest PolyPid (PYPD) rating was a maintained with a price target of $10.00 to $9.00. The current price PolyPid (PYPD) is trading at is $4.04, which is out of the analyst’s predicted range.